• Business Development Companies and Financial Institutions

    • Barings BDC, Inc. (NYSE: BBDC) in its acquisition of MVC Capital, Inc. (NYSE: MVC).
    • Harvest Capital Credit Corporation (formerly NASDAQ: HCAP) and the special committee HCAP’s board of directors in HCAP’s sale to Portman Ridge Finance Corporation (NASDAQ: PTMN).
    • Alcentra Capital Corp. (formerly Nasdaq: ABDC), a business development company, in its cash and stock merger with Crescent Capital Corp. (NYSE: CCAP).
    • Barings LLC, one of the world's leading asset management firms, in becoming the external investment adviser to Barings BDC, Inc. ((NYSE: BBDC); f/k/a Triangle Capital Corporation (NYSE: TCAP)), a business development company.
    • FS Investment Corporation II, FS Investment Corporation III, FS Investment Corporation IV and Corporate Capital Trust II in their merger to create the second largest business development company by assets under management (FS KKR Capital Corp. II) and subsequent listing on the New York Stock Exchange (NYSE: FSKR), and FSKR and FS KKR Capital Corp. (NYSE: FSK) in their subsequent merger.
    • FS Investments in its acquisition of Chiron Investment Management.
    • Bain Capital Specialty Finance, Inc. (NYSE: BCSF) in its joint venture with the private credit business of Pantheon, a leading global alternative private markets manager, to provide private direct lending solutions to middle market borrowers primarily across Europe and Australia.
    • Cliffwater LLC in its joint venture with TCG BDC, Inc. (NASDAQ: CGBD) to invest in senior-loan opportunities.
    • AIG in its acquisition of all the outstanding equity interests of Covenant Credit Partners, LP, an alternative credit manager with a focus on collateralized loan obligations.
    • Corporate Capital Trust, Inc. (formerly NYSE: CCT) in the listing of its shares on the NYSE and its subsequent merger with FS KKR Capital Corp. (NYSE: FSK).
    • Numerous business development companies sponsored by FS Investments in connection with their capital markets activities and general corporate and securities matters.
    • PennantPark Investment Corporation and PennantPark Floating Rate Capital Ltd. in connection with their capital markets activities and general corporate and securities matters.
    • Whitehorse Finance, Inc. in connection with its capital markets transactions.
    • JetPay Corporation (formerly NASDAQ: JTPY), a leading provider of vertically integrated solutions for businesses including card acceptance, processing, payroll, payroll tax filing, human capital management services, and other financial transactions, in its US$184 million acquisition by NCR Corporation (NYSE: NCR). 

    Private Equity and Strategic Companies

    • US Ecology, Inc. (Nasdaq: ECOL) in its US$966 million merger with NRC Group Holdings Corp. and general corporate matters.
    • MiddleGround Capital in its acquisition of a majority ownership in Dura Automotive Systems from Bardin Hill Investment Partners.
    • One Equity Partners in its carve-out acquisition of Anvil International, a leading North American manufacturer of high quality pipe fitting and system components from Mueller Water Products, and the subsequent merger of Anvil International with Smith-Cooper International; in its acquisition of Rizing LLC, an international company that provides leading SAP functional and technical consulting services to its customers; in its acquisition of a majority interest in The W.W. Williams Company, a leader in truck repair and diesel repair; and in advising a number of portfolio companies on add-on acquisitions.
    • Kofax Limited (formerly NASDAQ: KFX), a leading provider of smart process applications, in its US$1 billion sale to Lexmark International, Inc. (formerly Nasdaq: LXK), a global imaging leader, and Lexmark International, Inc. in its subsequent sale of its Enterprise Software business to Thoma Bravo.
    • Edge Therapeutics (formerly NASDAQ: EDGE), a U.S.-based biotechnology company, in its merger with PDS Biotechnology Corporation, a clinical-stage cancer immunotherapy company (NASDAQ: PDBS).
    • Aviragen Therapeutics, Inc. (formerly NASDAQ: AVIR), a biopharmaceutical company that had been focused on the discovery and development of products to prevent and treat infectious diseases, in its merger with Vaxart, Inc. (NASDAQ: VXRT).